Kali Inc. (KALY)

[BottomTurn]

Between now and the April 17thpresentation, KALY plans to mention several key updates regarding their business operations separate from the cannabis extract pharmaceutical research and development business. These announcements will be further incorporated into the upcoming April 17th presentation. The announcements and supplementary presentation material pertains to where KALY is generating revenue from its patented cannabis extraction process delivering proprietary extracts for infusion into non-pharmaceutical commercial products. For instance, KALY recently announced finalizing its all new 25 mg CBD Extract formulation for beverage infusion. KALY’s patented extraction process already produces a 10 mg CBD formulation for Puration, Inc.’s (PURA) (“PURA”) leading EVERx CBD Sports Water. Management plans to include in the presentation updates on how the 25 mg CBD Extract formulation pertains to KALY and PURA’s contract to produce a private labeled CBD water for Generex Biotechnology, Corp. (GNBT).